top of page
The Professional Network for Healthcare Experts
FDA approves Telix Pixclara as first FET-PET imaging drug for glioma
The FDA has approved Telix's Pixclara as the first FET-PET imaging agent in the United States for evaluating glioma, providing a new tool to help distinguish tumour progression from treatment-related changes.
nuaxia
Sep 142 min read
FDA approves TAUKLARIFY as new tau PET imaging agent for Alzheimer's disease evaluation
The approval provides clinicians with a new PET imaging agent to identify tau neurofibrillary tangle pathology in adults undergoing assessment for Alzheimer's disease, complementing existing diagnostic tools.
nuaxia
Aug 212 min read
bottom of page